Chemical Business Newsbase articles from April 2011, page 6

Chemical Business Newsbase archives from April 2011

GW Pharmaceuticals release: Sativex approved in the Czech Republic.
April 15, 2011... GW Pharmaceuticals plc has announced that Sativex oromucosal spray has been approved in the Czech Republic as a treatment for spasticity due to multiple sclerosis. This approval follows GW Pharmaceuticals' announcement on 22 Mar 2011 that the...

Trophos presents results data at the American Academy of Neurology on SMA and multiple sclerosis.(Clinical report)
April 15, 2011... Trophos SA has announces that the company has described the design of its pivotal clinical study of olesoxime in spinal muscular atrophy (SMA) via a poster presentation at this week's 6th Annual American Academy of Neurology (AAN) meeting held...

Thermo Fisher Scientific (TMO) introduces new tools to study active serine hydrolases.
April 15, 2011... Thermo Fisher Scientific announced the introduction of novel reagents for the study of active serine hydrolases. The Thermo Scientific ActivX Serine Hydrolase Probes contain a fluorphosphonate (FP) element that specifically binds to the active...

Trius Therapeutics awarded third Government contract to develop novel antibiotics.
April 15, 2011... Trius Therapeutics Inc (Trius) has been awarded a research contract by Lawrence Livermore National Laboratory (LLNL), part of the US Department of Energy's National Nuclear Security Administration, for the development of novel antibiotics...

GlaxoSmithKline to shed its diet drug, Alli and other OTC brands.
April 15, 2011... Four years after launching the nonprescription diet pill Alli with much fanfare and a heavy marketing budget, UK drug maker GlaxoSmithKline PLC said that it plans to sell off the drug along with a clutch of other over-the-counter brands....

GlaxoSmithKline selling Memphis manufacturing facility, 250 jobs affected.
April 15, 2011... GlaxoSmithKline will sell its Memphis manufacturing operation. The pharmaceutical and health care giant employs 250 people locally at its Presidents Island plant. GlaxoSmithKline plans to divest a number of its over-the-counter brands, including...

EU Agency flags narcolepsy risk on GlaxoSmithKline flu shot.
April 15, 2011... European regulators have recommended changes to the product label for GlaxoSmithKline's pandemic flu vaccine Pandemrix to highlight the potential risk of narcolepsy in children or adolescents. The decision is based on preliminary results of...

As generics near, makers including Pfizer Inc tweak erectile drugs.
April 15, 2011... Facing generic competition for its 'little blue pill,' Pfizer recently started selling a chewable form of Viagra in Mexico. It is called Viagra Jet, and Pfizer says it may also market it to other nations in the developing world, if not the US....

Glencore sails straight into FTSE with GBP 6.7 bn flotation.
April 15, 2011... Glencore has unveiled plans for a mammoth listing in May 2011 that will make the Swiss commodities trader only the third company ever to warrant immediate inclusion into the FTSE 100 index of leading shares. The dual London and Hong Kong float...

BP fights on for Rosneft deal as TNK talks end.
April 15, 2011... BP secured a last-minute extension to its $10 bn (GBP 6 bn) tie-up with Rosneft on 14 Apr 2011, as the oil giant faced down environmental protesters and shareholder rebellion at its annual general meeting. BP now has until 16 May 2011 to find a...

Manufacturer of controlled substances; notice of registration (Siegfried (USA) Inc.
April 15, 2011... Siegfried (USA) Inc, 33 Industrial Park Road, Pennsville, NJ, USA, made application by letter to the US Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of hydromorphinol, a basic class of controlled substance in...

Tyre, tube imports may skid on quality roadblock.
April 15, 2011... Imports of tyres and tubes are likely to decline by 30-40% after 13 Mar 2011 till Jul 2011 following the new Government rules that makes it mandatory for all tyres sold in India to conform to standards prescribed by the Bureau of Indian...

Dr Reddy's launches anti-allergy drug in US.
April 15, 2011... The Hyderabad-based pharma major has introduced its anti-allergy drug Fexofenadine HCl tablets in the US. The company plans to market the drug under store brand labels, over the counter, in the US. The sales of Fexofenadine HCl brand and...

Users want Rubber Board inspection of imports stopped: Claim delay in clearance affecting production.
April 15, 2011... All India Rubber Industries Association and Automotive Tyre Manufacturers' Association have urged the Rubber Board to stop random inspection of imported natural rubber, as it causes delay that affects production process. These two associations...

Bayer MaterialScience raises prices for aromatic isocyanate derivatives.
April 15, 2011... Effective 1 May 2011, Bayer MaterialScience AG is raising its selling prices for aromatic isocyanate derivatives in the Europe, Middle East, Africa (EMEA) region by averaged 6 %. This price increase affects Desmodur L, Desmodur IL, Desmodur HL,...

Bayer MaterialScience raises prices for polyurethane raw materials in Europe.
April 15, 2011... Bayer MaterialScience AG is raising the selling prices for all products of its polyurethane segment in the Europe, Middle East, Africa (EMEA) region by EUR 0.30 per kilogram, effective 1 May 2011. Substantially higher raw material and utilities...

Celanese announces acetone derivatives price increases,.
April 15, 2011... Celanese Corp will increase list and off-list selling prices for the following products, in the amounts indicated, effective 1 May 2011, or as contracts allow. MIBC $0.06/lb in the US, Canada, Mexico, Central & South America; EUR 130/tonne...

Be different! Clariant showcases efficiency, color and performance boosting-solutions.
April 15, 2011... Clariant promotes differentiation in the home and industrial cleaning, fabric and personal care sectors, with its efficiency-, color- and performance-boosting ingredients on-show at the HPCI Turkey Congress, 1 to 2 Jun 2011. At Booth 212,...

Eastman increases ketone prices on 1 May 2011.
April 15, 2011... On 15 Apr 2011, Eastman Chemical Co announced that it is increasing prices on the following products 1 May 2011, or as contracts allow. These increases are due to elevated operating costs, particularly in raw materials and energy. Eastman MIBK:...

Eastman increases plasticizers prices on 1 May 2011.
April 15, 2011... On 15 Apr 2011, Eastman Chemical Co announced that it increasing prices on the following products May. 1, or as contracts allow. These increases are due to increased market demand and operating costs, particularly in raw materials. EASTMAN DOP:...

LANXESS to expand capacities for high-performance rubber in US.
April 15, 2011... LANXESS is further expanding its capacities to produce solution styrene butadiene (SSBR) and neodymium polybutadiene (Nd-PBR) rubbers in order to meet growing global demand for high-performance, environmentally friendly 'green tires'. An...

Impact of great eastern Japan earthquake on operations (No 5).
April 15, 2011... The Mitsui Chemicals Group updates previous reports on the effects of the 11 Mar 2011 Great Eastern Japan Earthquake on its operations. In restarting operations at the company's Works, Mitsui Chemicals continues to assess the effects of the...

High-ranking Chinese delegation visits Evonik.
April 15, 2011... China's Yu Zheng Sheng, party chief for the City of Shanghai, China, and member of the Politbureau of the Communist Party's Central Committee, visited Evonik Industries in Essen, Germany, on 15 Apr 2011 as part of a delegation of 30. Atop Evonik...

BYK announces price increase.
April 15, 2011... BYK Additives & Instruments will increase prices for its product lines of wax, paint, plastics and industrial application additives between 5% and 9%, or more for selected products, effective 15 May 2011. The price increase is to offset...

New and generic drug approvals: Olmesartan Medoxomil and Hydrochlorothiazide Oral Tablet, Mylan Pharma.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced the tentative approval of ANDA/ 078827 for Olmesartan Medoxomil and Hydrochlorothiazide Oral Tablet. The product contains olmesartan medoxomil at 20mg or 40mg and hydrochlorothiazide...

New and generic drug approvals: Venlafaxine Hydrochloride Extended Release Oral Capsule, Biovail Labs International.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of ANDA 090071 for Venlafaxine Hydrochloride Extended Release Oral Capsule. The product contains venlafaxine hydrochloride at 37.5mg, 75mg, or 150mg, is manufactured by...

New and generic drug approvals: Epirubicin Hydrochloride Injection, Mustafa Nevsat. [2 tables in original article].
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of ANDA 090266 for Epirubicin Hydrochloride Injection. The product contains epirubicin hydrochloride at 50mg/25ml or 200mg/100ml, is manufactured by Mustafa Nevsat, and is...

New and generic drug approvals: Amlodipine Besylate Oral Tablet, Secan Pharms. [2 tables in original article].
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of ANDA 090752 for Amlodipine Besylate Oral Tablet. The product contains amlodipine besylate at 5mg or 10mg (eq base), is manufactured by Secan Pharms, and is prescription...

New and generic drug approvals: Doxercalciferol Injection, Sandoz.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced the tentative approval of ANDA 091333 for Doxercalciferol Injection. The product contains doxercalciferol at 2 microgram/ml and is manufactured by Sandoz. There are no therapeutic...

New and generic drug approvals: Actemra Injection, Genentech.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of BLA 125276 (control supplement) for Actemra Injection. The product contains tocilizumab at 80mg/4ml, 200mg/10ml, or 400mg/20ml, is manufactured by Genentech, and is...

New and generic drug approvals: Imiquimod Topical Cream, Taro. [1 table in original article].
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of NDA 200173 for Imiquimod Topical Cream. The product contains imiquimod at 5%, is manufactured by Taro, and is prescription only. There are five therapeutic equivalents...

New and generic drug approvals: Lotemax Ophthalmic Ointment, Bausch and Lomb.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration announced approval of NDA 200738 for Lotemax Ophthalmic Ointment. The product contains loteprednol etabonate at 0.5%, is manufactured by Bausch and Lomb, and is prescription only. There are no...

FDA approves Actemra to treat rare form of juvenile arthritis.
April 15, 2011... On 15 Apr 2011, the US Food and Drug Administration approved Actemra (tocilizumab), given alone or in combination with methotrexate, for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in children ages 2 years and older....

Sun Chemical Corp; filing of colour additive petition.
April 14, 2011... The US Food and Drug Administration (FDA) is announcing that Sun Chemical Corp has filed a petition proposing that the color additive regulations for D&C Red No 6 and D&C Red No 7 be amended by replacing the specification for...

Reliance Ind begins polyester capacity expansion.
April 14, 2011... Reliance Industries Ltd has started implementing its planned expansion projects in the polyester sector. The company will add 2.3 M tonnes of polyester capacity in several phases at its Dahej facility and increase the capacity further by 1.15 M...

GSK Pharma told to pay Rup 71.21 crores in over-pricing case.
April 14, 2011... The Supreme Court has set aside the order of the Delhi High Court and has directed the pharma firm GlaxoSmithKline Pharmaceuticals to pay Rup 71.21 crores to the Government for over-pricing of its drugs. The 20-year old dispute between the...

New and generic drug approvals: Venlafaxine Hydrochloride Extended Release Oral Capsule, Wockhardt.
April 14, 2011... On 14 Apr 2011, the US Food and Drug Administration announced approval of ANDA 078865 for Venlafaxine Hydrochloride Extended Release Oral Capsule. The product contains venlafaxine hydrochloride at 75mg, or 150mg, is manufactured by Wockhardt,...

New and generic drug approvals: Venlafaxine Hydrochloride Extended Release Oral Capsule, Zydus Pharms USA.
April 14, 2011... On 14 Apr 2011, the US Food and Drug Administration announced approval of ANDA 090174 for Venlafaxine Hydrochloride Extended Release Oral Capsule. The product contains venlafaxine hydrochloride at 37.5mg, 75mg, or 150mg, is manufactured by Zydus...

New and generic drug approvals: Letrozole Oral Tablet, Endo Pharms.
April 14, 2011... On 14 Apr 2011, the US Food and Drug Administration announced the tentative approval of ANDA 090789 for Letrozole Oral Tablet. The product contains letrozole at 2.5mg and is manufactured by Endo Pharms. There are no therapeutic equivalents.

New and generic drug approvals: Paroxetine Hydrochloride Extended Release Oral Tablet, Mylan Pharma.
April 14, 2011... On 14 Apr 2011, the US Food and Drug Administration announced approval of ANDA 091427 for Paroxetine Hydrochloride Extended Release Oral Tablet. The product contains paroxetine hydrochloride at 37.5mg, is manufactured by Mylan Pharma, and is...

New and generic drug approvals: Venlafaxine Hydrochloride Extended Release Oral Capsule, Aurobindo Pharma.
April 14, 2011... On 14 Apr 2011, the US Food and Drug Administration announced approval of ANDA 200834 for Venlafaxine Hydrochloride Extended Release Oral Capsule. The product contains venlafaxine hydrochloride at 37.5mg, 75mg, or 150mg, is manufactured by...

Air Liquide will invest more than EUR 22 M in the construction and operation of a new air separation unit.
April 14, 2011... The Philippines, a newly industrialized country, experienced a record GDP growth rate of 7.3% in 2010. In recent years, its formerly agriculture-based economy has been transforming itself into a services and manufacturing-based economy. The...

New herbicide Alion registered in the US.
April 14, 2011... The innovative non-selective herbicide Alion (active ingredient indaziflam) from Bayer CropScience has been granted regulatory approval in the US by the Environmental Protection Agency (EPA). Alion was developed primarily for use in perennial...

Bayer's rivaroxaban submitted for approval in Japan.
April 14, 2011... Bayer's rivaroxaban (Xarelto) has been submitted for marketing approval in the prevention of stroke in patients with atrial fibrillation to the Japanese Ministry of Health, Labor and Welfare (MHLW). The submission to the MHLW is based on the...

Lolly Baby enhances nursing bottles, pacifiers with clear, durable Eastman Tritan copolyester.
April 14, 2011... To meet customer demand for infant care products with glasslike clarity, Brazilian infant care company Lolly Baby is producing a line of baby nursing bottles and pacifiers utilizing Eastman Tritan copolyester. Tritan is a new-generation material...

Eastman increases isophthalic acid prices on 1 May 2011.
April 14, 2011... On 14 Apr 2011, Eastman Chemical Co announced that is increasing prices on the following products 1 May 2011, or as contracts allow. These increases are due to elevated operating costs, particularly in raw materials. Eastman Isophthalic Acid:...

Eastman 168 non-phthalate plasticizer receives additional US FDA food contact clearance.
April 14, 2011... On 14 Apr 2011, Eastman Chemical Co announced that the US FDA has expanded food contact clearance for its Eastman 168 non-phthalate plasticizer. Food Contact Notification (FCN) 1056 permits the use of Eastman 168 to be used in contact with all...

Eastman increases oxo alcohols prices on 1 May 2011.
April 14, 2011... On 14 Apr 2011, Eastman Chemical Co announced that it is increasing prices on the following products 1 May 2011, or as contracts allow. These increases are due to increased market demand and operating costs, particularly in raw materials,...

Innovations in chemistry for sustainable mobility.
April 14, 2011... LANXESS will be exhibiting at the 11th Challenge Bibendum, organized by the Michelin Group, this year on the grounds of the former Berlin-Tempelhof Airport. "This event is considered one of the world's foremost specialist- and discussion forums...

Evonik expands its L-Tryptophan capacity.
April 14, 2011... Evonik Industries AG announces a capacity increase of TrypAmino (L-Tryptophan) at Evonik Fermas sro, a 100% affiliated company of Evonik AG, in Slovenska Lupca, Slovakia. The Tryptophan plant will be expanded to a final capacity of 2000...

Solutia to supply heat transfer fluids for world's largest solar generation plant.
April 14, 2011... Solutia Inc has been awarded a contract to supply its Therminol VP-1 synthetic heat transfer fluid for the Solana solar power plant project. The $2 bn plant, which is under construction in Gila Bend, AZ, USA, is a large parabolic trough...

Handy skin care for active men UL OS Refresh Sheet (Medicated Cosmetic) launches on 21 Apr 2011.
April 14, 2011... Otsuka Pharmaceutical Co Ltd announced on 14 Apr 2011 the launch of a new addition to its UL OS skin care brand on 21 Apr 2011. The new UL OS Refresh Sheet (medicated cosmetic) offers simple skin care at any time and any place for active men in...

The next generation of ingredient traps: Symrise dedicates the new SymTrap plant in Hamburg.
April 14, 2011... Symrise AG is putting the new SymTrap plant into service on 14 Apr 2011 at the Hamburg site in Germany. The SymTrap process applies to volatile flavouring substances and can be used to increase the concentration of bioactive ingredients in...

Cubist Pharmaceuticals 1Q 2011 total net revenues up 13% to $162.5 M; 1Q 2011 US net revenues for Cubicin up 14% to $153.7 M.(Financial report)
April 14, 2011... Cubist Pharmaceuticals Inc (Cubist) announced results for the 1Q ended Mar 2011. Cubist's total net revenues for 1Q 2011 increased 13% to $162.5 M ($144.1 M in 1Q 2010). This increase was attributable primarily to Cubist's net sales of Cubicin...

Agrofert Holding has purchased 80% of shares in Wotan group companies.
April 14, 2011... Agrofert Holding (AH) (Czech Republic), agrochemical and food holding, bought 80% of shares in companies of the forestry and wood processing group Wotan (Czech Republic) in spring 2011. AH has entered a new sector thanks to the purchase. AH has...

Reckitt chief Bart Becht to step down.
April 14, 2011... One of Britain's highest paid bosses announced on 14 Apr 2011 that he is stepping down after 16 years as chief executive of household goods giant Reckitt Benckiser. Bart Becht is to hand over the reins to Reckitt veteran Rakesh Kapoor in Sep...

BP wins more time for Russian deal.
April 14, 2011... Oil giant BP has secured more time to salvage its GBP 10 bn share-swap and exploration deal with Russian-government owned Rosneft. The embattled supermajor extended today's deadline to complete the agreement following last-minute negotiations...

Unilever and P&G fined EUR 300 M for price-fixing.
April 14, 2011... European regulators have ordered Procter & Gamble, the maker of Tide, Gain and Era washing power brands, and Unilever, whose brands include Omo and Surf, to pay fines totalling more than EUR 300 M (GBP 267 M) for their part in a cartel that...

Gene research brings schizophrenia hope.
April 14, 2011... Skin cells from patients suffering from schizophrenia have been turned into nerve cells, enabling scientists to "model" the disease in a test tube so that new drugs and treatments can be tested on the condition, which affects 1% of the...

ACC expects market share to cross 11% in 2011: Demand-supply imbalance in South a cause for concern, Chairman.
April 14, 2011... Cement major ACC expects its market share to increase to 11% in 2011 from the present 10.2%, following the completion of its Rup 825 crore expansion projects at Wadi in Karnataka, India and Chanda in Maharashtra, India. The overall capacity of...

Ecron Acunova buys 75% in Danish clinical research firm.
April 14, 2011... The Indian Clinical research firm Ecron Acunova has acquired 75% stake the Danish clinical research firm ACROnordic, which has 40 employees and located near Copenhagen. The Danish firm has presence in Sweden and Finland and hence Ecron Acunova...

Uflex investing $180 M in new US facility.
April 14, 2011... Flexible packagings firm Uflex Ltd proposes to invest $180 M in phases to set up a 30,000 tonnes/y greenfield PET film plant in Kentucky, US. At present, the company manufactures 25,000 tonnes/y packaging solutions.

American crop protection firm eyes buys in India.
April 14, 2011... The US-based crop protection solutions major Chemtura Corp has set a sales target of $100 M from its Indian operations in crop protection chemicals segment. At present, the company derives revenues of $100 M from its Indian operations, with crop...

Commission Implementing Directive 2011/45/EU of 13 Apr 2011 amending Council Directive 91/414/EEC to include diclofop as active substance and amending Commission Decision 2008/934/EC.
April 14, 2011... Adopted on 13 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the market,...

Commission Implementing Directive 2011/44/EU of 13 Apr 2011 amending Council Directive 91/414/EEC to include azadirachtin as active substance and amending Commission Decision 2008/941/EC.
April 14, 2011... Adopted on 13 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the...

Commission Implementing Directive 2011/43/EU of 13 Apr 2011 amending Council Directive 91/414/EEC to include lime sulfur as active substance and amending Commission Decision 2008/941/EC.
April 14, 2011... Adopted on 13 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Council Directive 91/414/EEC of 15 Jul 1991 concerning the placing of plant protection products on the...

Commission Regulation (EU) No 363/2011 of 13 Apr 2011 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substanc.
April 14, 2011... Adopted on 13 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community...

Commission Regulation (EU) No 362/2011 of 13 Apr 2011 amending the Annex to Regulation (EU) No 37/2010 on harmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance.
April 14, 2011... Adopted on 13 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community...

Commission Implementing Regulation (EU) No 361/2011 of 13 Apr 2011 concerning the authorisation of Enterococcus faecium NCIMB 10415 as a feed additive for chickens for fattening (holder of authorisation DSM Nutritional products Ltd represented by DSM Nutr.
April 14, 2011... Adopted on 13 Apr 2011. The European Commission, having regard to the Treaty on the Functioning of the European Union, having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 Sep 2003 on additives for...

Prior notification of a concentration (Case COMP/M.6151 - PetroChina/Ineos/JV).
April 14, 2011... On 5 Apr 2011, the European Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which PetroChina International (London) Co Ltd (PCIL, UK), wholly owned by PetroChina Co...

Notice of the impending expiry of certain countervailing measures. [1 table in original article].
April 14, 2011... As provided for in Article 18(4) of Council Regulation (EC) No 597/2009 of 11 Jun 2009 on protection against subsidised imports from countries not members of the European Community, the European Commission gives notice that, unless a review is...

Solar Junction breaks world record with 43.5% efficient CPV production cell.
April 14, 2011... Solar Junction has announced that it has set a world-record for 43.5% efficiency on a commercial-ready production cell. This achievement was, in part, supported under the US Department of Energy (DOE) PV Incubator Programme, managed through...

Rentech receives term sheet for loan guarantee from US Department of Energy for recently-acquired advanced-stage renewable power project in Florida.
April 14, 2011... Rentech Inc has announced that it has received a term sheet for a loan guarantee from the US Department of Energy (DOE) under the Section 1705 Title XVII Loan Guarantee Programme, for an advanced-stage renewable power project in Port St Joe, FL,...

Satcon selected for 15 MW solar PV project by Solon.
April 14, 2011... Satcon Technology Corp (Satcon) has announced that it has been selected by Solon to supply twelve 1.25 MW Prism Platforms for Pacific Gas and Electric's (Pacific Gas) upcoming 15 MW ground mount installation near Fresno, CA. The project is part...

Lithium-ion battery maker Leyden Energy unveils its first high-performance cylindrical battery for electric vehicles.
April 14, 2011... Leyden Energy Inc (Leyden) has announced that it will provide its industry-leading high energy density, high-performance cylindrical battery cells for SSI Racing's marquee Dream Car at the annual Toyota Grand Prix of Long Beach. The Dream Car,...

New Resource Bank, Enfinity team up on solar projects.
April 14, 2011... New Resource Bank (New Resource) and Enfinity are teaming up to expand solar energy production in California and across the US. New Resource will provide a line of credit and other banking services to support Enfinity's construction of solar...

Genencor completes transformation of textile enzymes portfolio, adds new sustainable enzymes.
April 14, 2011... Genencor has announced that it has completed its textile portfolio transformation by adding new products to its family of enzymes, providing textile mills and garment laundries with a full suite of enzyme solutions. Genencor enzymes improve the...

Dr Reddy's announces the launch of over-the-counter fexofenadine hydrochloride tablets.
April 14, 2011... Dr Reddy's Laboratories Ltd (Dr Reddy's) has announced that it has launched its over-the-counter (OTC) fexofenadine hydrochloride tablets on 13 Apr 2011. The Food & Drug Administration (FDA) approved Dr Reddy's abbreviated new drug...

RXi Pharmaceuticals completes Apthera acquisition.
April 14, 2011... RXi Pharmaceuticals Corp (RXi) has announced the completion of its previously announced acquisition of Apthera Inc. The acquisition provides RXi with a late stage product candidate, NeuVax, a peptide-based immunotherapy for low-to-intermediate...

Regulus Therapeutics and UC San Diego to collaborate on angiogenic disease research utilizing microRNA technology .
April 14, 2011... Regulus Therapeutics Inc (Regulus) has announced that it is collaborating with researchers at the University of California, San Diego (UC San Diego) School of Medicine seeking novel treatments for angiogenic diseases using microRNA therapeutics....

InSite Vision updates special protocol assessment submission to FDA for Phase III trial of AzaSite Plus and DexaSite.
April 14, 2011... InSite Vision Inc has (InSite) announced that the company recently received eight minor recommendations regarding its proposed agreement with the US Food and Drug Administration (FDA) under its special protocol assessment (SPA) process for the...

Neurotech's NT-501 implant demonstrates statistically significant photoreceptor preservation in patients with retinal degenerative disease.
April 14, 2011... Neurotech Pharmaceuticals Inc (Neurotech) has announced that, as reported in Investigative Ophthalmology & Visual Science (Apr 2011), the company's product candidate NT-501 demonstrated statistically significant cone photoreceptor...

New study demonstrated significant reduction in annualised relapse rate and halting of disability progression in MS patients switching to Copaxone.
April 14, 2011... Teva Pharmaceutical Industries Ltd announced preliminary data from two studies, Coptimize and QualiCop. The global Coptimize study, which followed 688 patients from 19 countries, demonstrated that patients who switched to Copaxone (glatiramer...

Five-year alemtuzumab Phase II data shows large percentage of MS patients remain free of clinically-active disease.
April 14, 2011... Genzyme Corp reported additional five-year patient data from its completed Phase II multiple sclerosis (MS) trial showing that nearly two-thirds of alemtuzumab treated patients remained free of clinically-active disease as much as four years...